In Flux: The Current State of Goodwill & Impairment
As public companies enter the traditional fourth-quarter impairment testing period, two big question marks are hanging over the market…
As public companies enter the traditional fourth-quarter impairment testing period, two big question marks are hanging over the market…
Gain practical valuation modeling insights on identifying and quantifying synergies within the deal model, and with a bit of holiday spirit.
Just released! Read VRC’s latest Industry Update on Software for relevant market data, trends in EBITDA multiples, notable deals and more.
In the November issue, Bloomberg publishes Mutarelli’s third-quarter analysis results of valuations and impairment testing, including potential goodwill impairment.
Just released! Read VRC’s latest Industry Update on Fire Prevention for relevant market data, trends in EBITDA multiples, notable deals and more.
Featured in the October issue, Mutarelli analyzes how to approach valuations and impairment testing when managing through the impacts of COVID.
VRC’s latest Industry Update on Technology was just released! Take a look to learn about relevant trends in EBITDA, market data, multiples, notable deals and more.
Read VRC’s latest Industry Update on Specialty Chemicals for relevant market data, trends in EBITDA multiples, notable deals and more.
Just released! VRC’s latest Industry Update on Medical Devices for relevant market data, trends in EBITDA multiples, notable deals and more.
VRC just released it’s latest Industry Update on Pharmaceuticals! Read more for relevant market data, trends in EBITDA multiples, notable deals and more.